Maffeis, Claudio http://orcid.org/0000-0002-3563-4404
Rabbone, Ivana http://orcid.org/0000-0003-4173-146X
Funding for this research was provided by:
Sanofi s.r.l.
Università degli Studi di Verona
Article History
Accepted: 14 June 2022
First Online: 26 July 2022
Declarations
:
: Open access funding provided by Università degli Studi di Verona within the CRUI-CARE Agreement. Financial support for the development of this manuscript was provided by Sanofi. No payments or honoraria were made to the authors with respect to manuscript preparation.
: Claudio Maffeis has received honoraria from Sanofi, Eli Lilly, Novo Nordisk and Sandoz for lectures including service on speaker bureaus and consulting fees from Abbot, Roche and Sanofi. Ivana Rabbone has received honoraria from Sanofi, Eli Lilly, Abbott, Aboca, Theras and Ypsomed for lectures including service on speaker bureaus.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors made substantial contributions to the conception of the work and contributed equally to it. All authors revised the article critically for important intellectual content, sharing responsibility for the statements included in the text. All authors approved the final version to be published.